Recognizing The Clinical Features Of Mogad For Diagnosis

Recognizing the Clinical Features of MOGAD for Diagnosis

Advancements in MOGAD diagnosis: key features of the new guidelines

Current MOGAD criteria and the role of MRI in diagnosis

The pathology of MS and MOGAD: similarities and differences

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)

Mayo Clinic Laboratories

Proposed criteria for the diagnosis of MOGAD

MOG Antibody Disease (MOGAD) Symptoms & Presentations

2020 RNDS | What is MOG Antibody Disease (MOGAD)?

SRNA

912. MOG Antibody Disease: Diagnosis and Treatment Guidelines

SRNA

NMO MOG Treatment Approach

Neuro-Ophthalmology with Dr. Andrew G. Lee

MOGAD (Myelin Oligodendrocyte Glycoprotein Associated Disease) Explained by Neurologist

Dr. Brandon Beaber

Predicting relapses in MOGAD

205. MOGAD and NMOSD: Is MOGAD Part of NMOSD or a Distinct Diagnosis?

SRNA

Navigating Through the International MOGAD Panel Proposed Diagnostic Criteria

The MOG Project

Research developments in MOGAD

Treatment Options for MOGAD

The Sumaira Foundation

Understanding Clinical Trials for MOGAD & the Importance of Patient Participation

The Sumaira Foundation

Diagnostic criteria and treatment updates for NMOSD

2022 RNDS | Learn about new clinical trials in MOGAD

SRNA

METEOROID: Phase III trial of satralizumab in patients with MOGAD